Notify me when dievini Hopp BioTech holding GmbH & Co KG files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVAC | CUREVAC N.V. | Common Shares, par value (euro)0.12 per share | 36.7% | $280M | 82.4M | Dietmar Hopp | Jun 12, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|